12 Health Care Stocks Moving In Thursday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • TC BioPharm (Holdings) TCBP shares rose 31.0% to $1.31 during Thursday's pre-market session. The company's market cap stands at $36.7 million.
  • Orphazyme ORPH shares increased by 26.71% to $0.83. The market value of their outstanding shares is at $29.3 million.
  • Eiger BioPharmaceuticals EIGR stock rose 23.9% to $7.05. The market value of their outstanding shares is at $244.2 million.
  • INVO Bioscience INVO stock rose 15.96% to $2.76. The market value of their outstanding shares is at $32.6 million.
  • Soligenix SNGX stock rose 13.86% to $0.78. The market value of their outstanding shares is at $33.4 million.
  • F-star Therapeutics FSTX shares increased by 13.08% to $3.37. The company's market cap stands at $70.9 million. As per the news, the Q4 earnings report came out 3 days ago.
  •  

Losers

  • China SXT Pharmaceuticals SXTC shares decreased by 10.5% to $0.19 during Thursday's pre-market session. The company's market cap stands at $5.5 million.
  • Unicycive Therapeutics UNCY shares declined by 9.91% to $1.0. The market value of their outstanding shares is at $14.9 million.
  • Signify Health SGFY shares declined by 8.64% to $15.77. The market value of their outstanding shares is at $2.7 billion.
  • Corbus Pharmaceuticals CRBP shares decreased by 7.64% to $0.38. The company's market cap stands at $47.6 million.
  • Aeglea BioTherapeutics AGLE stock decreased by 7.06% to $2.24. The company's market cap stands at $110.5 million.
  • Eton Pharmaceuticals ETON stock fell 6.88% to $3.66. The company's market cap stands at $90.0 million. The company's, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...